4/A//SEC Filing
SAMANT VIJAY B 4/A
Accession 0000911916-20-000126
CIK 0000819050other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:36 PM ET
Size
8.0 KB
Accession
0000911916-20-000126
Insider Transaction Report
Form 4/AAmended
SAMANT VIJAY B
DirectorPresident & CEO
Transactions
- Award
Stock Options
2020-02-14+2,167→ 2,167 totalExercise: $1.16From: 2020-02-14Exp: 2030-02-13→ Common Stock (2,167 underlying) - Award
Restricted Stock Units
2020-02-14+7,328→ 7,328 total→ Common Stock (7,328 underlying)
Footnotes (3)
- [F1]The Form 4 filed on February 19, 2020 inadvertently switched the number of restricted stock units and stock options granted. This amendment is being filed to reflect the correct numbers granted.
- [F2]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F3]These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020.
Documents
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001198238
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:36 PM ET
- Size
- 8.0 KB